Orkla Food Ingredients signs licence agreement with Renaissance BioScience Corp. for Acrylamide-Reducing Yeast Technology
(Thomson Reuters ONE) -
OSLO, Norway and VANCOUVER, British Columbia, May 23, 2017 (GLOBE NEWSWIRE) --
Orkla Food Ingredients, a business area of Orkla ASA (OSE:ORK) has signed a
licence agreement with Renaissance BioScience Corp. to exclusively produce and
sell Renaissance acrylamide-reducing yeast to food manufacturers in the European
Nordic and Baltic markets, starting in Q3 2017.
"Renaissance's acrylamide-reducing yeast has shown promising results in baked
goods trials, and Orkla is pleased to be working with Renaissance to make this
valuable advance in food safety available to food manufacturers," says Thore
Svensson, Senior Vice President in Orkla Food Ingredients.
Dr. Cormac O'Cleirigh, Chief Business Development Officer at Renaissance
BioScience comments: "Orkla is the market leader in the Nordics and Baltics, and
we're pleased to be working with a partner that sees the importance of reducing
acrylamide in the food supply. This is a key region for the introduction of our
acrylamide-reducing yeast, given that it is where the presence of acrylamide has
the highest level of consumer awareness."
Renaissance's acrylamide-reducing yeast has shown promising results in large-
scale industrial trials in baked goods and snack foods, as well as in lab scale
tests in fries and coffee. This yeast was granted GRAS status by the U.S. FDA in
2016 - the same status as conventional baker's and brewer's yeasts. It is patent
pending and was developed using classical non-GMO techniques. Renaissance is
currently working with Orkla on final product development and commercial
rollout.
About Orkla
Orkla is a leading supplier of branded consumer goods and concept solutions to
the grocery, out-of-home and bakery markets in the Nordics, Baltics and selected
markets in Central Europe and India. Orkla is listed on the Oslo Stock Exchange
and its head office is in Oslo. In 2016, the Group had a turnover of
approximately NOK 38 billion, and 18,000 employees at year end.
About Renaissance BioScience Corp.
Renaissance BioScience Corp., based in Vancouver, Canada, is a privately held
applied life sciences company that develops novel, yeast-based, patent-protected
technologies for the global food, beverage, nutrition, biofuel and
pharmaceutical industries. The wholly owned commercial subsidiaries of
Renaissance BioScience Corp. include Renaissance Yeast Inc., which
commercializes H(2)S-preventing wine yeast; Renaissance Ingredients Inc., which
commercializes acrylamide-reducing yeast; and Bright Brewers Yeast Inc., which
commercializes beer yeast technologies. Detailed information about the
Renaissance group of companies can be accessed at www.renaissancebioscience.com.
Orkla ASA
Oslo, 23 May 2017
Ref.:
Orkla ASA
Group Director, Corporate Communications and Corporate Affairs
Håkon Mageli
Tel.: + 47 928 45 828
Email: hakon.mageli(at)orkla.no
Renaissance BioScience Corp.
Steve Campbell
Campbell & Company Strategies Inc.
Communications and Public Relations
Vancouver, BC CANADA
Tel.: 01 604 888-5267
Email: stevec(at)ccom-pr.com
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Renaissance BioScience Corp. via GlobeNewswire
Datum: 23.05.2017 - 23:56 Uhr
Sprache: Deutsch
News-ID 544229
Anzahl Zeichen: 3863
contact information:
Town:
Vancouver
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 167 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Orkla Food Ingredients signs licence agreement with Renaissance BioScience Corp. for Acrylamide-Reducing Yeast Technology"
steht unter der journalistisch-redaktionellen Verantwortung von
Renaissance BioScience Corp. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
